 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              The equity shares of Parabolic Drugs Ltd (BSE Scrip Code: 533211) was listed and admitted to dealings on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) from July 1, 2010.
The stock opened in BSE for the day at Rs 76, up by Rs.1 as compared to the IPO price of Rs 75 per share.
The stock was last trading in BSE at Rs.67.40, down by Rs.7.60 or 10.13%. The stock hit an intraday high of Rs.79 and low of Rs.65.30.
The total traded quantity was 5379841 at a weighted average price of Rs 69.01.